Bruce Brockstein to Camptothecin
This is a "connection" page, showing publications Bruce Brockstein has written about Camptothecin.
Connection Strength
0.127
-
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Cancer. 2009 Oct 01; 115(19):4504-13.
Score: 0.083
-
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer. Invest New Drugs. 2000 Aug; 18(3):261-3.
Score: 0.044